Literature DB >> 7040174

Leucocyte function in Crohn's disease. Studies on mobilisation using a quantitative skin window technique and on the function of circulating polymorphonuclear leucocytes in vitro.

J H Wandall, V Binder.   

Abstract

Leucocyte function was evaluated by mobilisation to skin windows with chambers and by the chemotactic, phagocytic, and nitro blue tetrazolium (NBT) reducing activity of circulating leucocytes in vitro in 20 patients with Crohn's disease, 21 healthy volunteers, and nine patients with sarcoidosis or tuberculosis. Leucocytes had been mobilised in significantly reduced numbers at 12, 24, 36, and 48 hours in Crohn's disease compared with healthy volunteers (P less than 0.01) and patients with sarcoidosis/tuberculosis (P less than 0.01). The leucocyte migration rate showed that mobilisation in Crohn's disease begins after a prolonged lag phase and is reduced compared with healthy volunteers (P less than 0.01) and patients with sarcoidosis/tuberculosis (P less than 0.02). The reduced mobilisation was not correlated with disease activity. In vitro random migration by leucocytes was slightly lower in Crohn's disease (P less than 0.05) than in healthy volunteers, but there was no difference after removal of the autologous plasma. Chemotactic response to casein did not differ between the groups studied. Serum independent and dependent phagocytosis did not differ from control groups. Serum independent phagocytosis was positively and significantly correlated to the disease activity (rho 0.4812, P less than 0.05). Resting leucocyte NBT reduction was increased in Crohn's disease and sarcoidosis/tuberculosis (P less than 0.01), but during phagocytosis a lower NBT reduction was found in Crohn's disease than in healthy volunteers (P less than 0.02). The inflammatory response in Crohn's disease, with reduced leucocyte accumulation, differs from patients with other granulomatous reactions and is independent of the disease activity. Our data suggest that the defect is not cellular. They support the hypothesis that a pathogenic factor in Crohn's disease may be foreign material that is normally eliminated remaining in the tissue and eliciting a chronic inflammatory response.

Entities:  

Mesh:

Year:  1982        PMID: 7040174      PMCID: PMC1419627          DOI: 10.1136/gut.23.3.173

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  15 in total

1.  The nitroblue tetrazolium test in Crohn's disease and ulcerative colitis.

Authors:  M Ward; M A Eastwood
Journal:  Digestion       Date:  1976       Impact factor: 3.216

2.  The granulomatous inflammatory response. A review.

Authors:  D O Adams
Journal:  Am J Pathol       Date:  1976-07       Impact factor: 4.307

3.  Acquired defect in the bactericidal function of neutrophil granulocytes during bacterial infections.

Authors:  C Koch
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1974-06

4.  An epidemiological study of regional enteritis and acute ileitis in Copenhagen County.

Authors:  L Höj; P B Jensen; O Bonnevie; P Riis
Journal:  Scand J Gastroenterol       Date:  1973       Impact factor: 2.423

5.  Neutrophil function in selected surgical disorders.

Authors:  J W Alexander; M Hegg; W A Altemeier
Journal:  Ann Surg       Date:  1968-09       Impact factor: 12.969

6.  Gastrointestinal manifestations of chronic granulomatous disease.

Authors:  M E Ament; H D Ochs
Journal:  N Engl J Med       Date:  1973-02-22       Impact factor: 91.245

7.  Defective neutrophil migration in sarcoidosis.

Authors:  R W Gange; M M Black; P Carrington; R McKerron
Journal:  Lancet       Date:  1977-08-20       Impact factor: 79.321

8.  Neutrophil dysfunction in Crohn's disease.

Authors:  A W Segal; G Loewi
Journal:  Lancet       Date:  1976-07-31       Impact factor: 79.321

9.  Humoral immune system activity in inflammatory bowel disease.

Authors:  P Teisberg; E Gjone
Journal:  Scand J Gastroenterol       Date:  1975       Impact factor: 2.423

10.  Skin reactivity and phagocytic function of neutrophil leucocytes in Crohn's disease and ulcerative colitis.

Authors:  U Krause; G Michaëlsson; L Juhlin
Journal:  Scand J Gastroenterol       Date:  1978       Impact factor: 2.423

View more
  26 in total

1.  Smoking and inflammatory bowel diseases: what in smoking alters the course?

Authors:  A M El-Tawil
Journal:  Int J Colorectal Dis       Date:  2010-03-24       Impact factor: 2.571

2.  Polymorphonuclear leucocytes in Crohn's disease and ulcerative proctocolitis: association between enhanced adherence to nylon fibre and disease variables.

Authors:  J Cason; C C Ainley; R A Wolstencroft; R P Thompson
Journal:  J Clin Pathol       Date:  1988-03       Impact factor: 3.411

Review 3.  Immunosuppressive drugs in inflammatory bowel disease. A review of their mechanisms of efficacy and place in therapy.

Authors:  A B Hawthorne; C J Hawkey
Journal:  Drugs       Date:  1989-08       Impact factor: 9.546

4.  Leucocyte function in ulcerative colitis. Quantitative leucocyte mobilisation to skin windows and in vitro function of blood leucocytes.

Authors:  J H Wandall; V Binder
Journal:  Gut       Date:  1982-09       Impact factor: 23.059

5.  Leucocyte function in patients with rheumatoid arthritis: quantitative in-vivo leucocyte mobilisation and in-vitro functions of blood and exudate leucocytes.

Authors:  J H Wandall
Journal:  Ann Rheum Dis       Date:  1985-10       Impact factor: 19.103

6.  In vivo assessment of granulocyte migration to diseased bowel in Crohn's disease.

Authors:  S H Saverymuttu; A M Peters; J P Lavender; V S Chadwick; H J Hodgson
Journal:  Gut       Date:  1985-04       Impact factor: 23.059

7.  Partial defect of neutrophil oxidative metabolism in Crohn's disease.

Authors:  H W Verspaget; M A Mieremet-Ooms; I T Weterman; A S Peña
Journal:  Gut       Date:  1984-08       Impact factor: 23.059

8.  Measurement of granulocyte migration and accumulation in inflammation in man.

Authors:  S H Saverymuttu; A M Peters; H J Reavy; J P Lavender
Journal:  Clin Exp Immunol       Date:  1983-06       Impact factor: 4.330

9.  Organelle pathology in ulcerative and Crohn's colitis with special reference to the lysosomal alterations.

Authors:  C O'Morain; P Smethurst; A J Levi; T J Peters
Journal:  Gut       Date:  1984-05       Impact factor: 23.059

Review 10.  Innate immunity in inflammatory bowel disease: a disease hypothesis.

Authors:  D J B Marks; A W Segal
Journal:  J Pathol       Date:  2008-01       Impact factor: 7.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.